2-pyrrolino-DOX

Known as: 2-pyrrolinodoxorubicin, 3'-deamino-3'-(2''-pyrroline-1''-yl)doxorubicin trifluoroacetate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Highly potent and novel derivatives of doxorubicin were linked to monoclonal antibodies (mAbs) for site-specific drug delivery… (More)
Is this relevant?
2004
2004
PURPOSE The targeted cytotoxic somatostatin analogue AN-238, consisting of 2-pyrrolinodoxorubicin (AN-201) linked to carrier… (More)
Is this relevant?
2003
2003
BACKGROUND New modalities are necessary for the treatment of patients with unresectable gastric carcinoma. The authors… (More)
Is this relevant?
2000
2000
The effectiveness of chemotherapy targeted to somatostatin (SST) receptors based on cytotoxic SST analogue AN-238, consisting of… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1999
1999
We evaluated whether AN-238, the cytotoxic analogue of somatostatin (SST) consisting of the radical 2-pyrrolinodoxorubicin (AN… (More)
Is this relevant?
1999
1999
BACKGROUND Receptors for luteinizing hormone-releasing hormone (LH-RH) found in prostate cancers might be used for targeting of… (More)
Is this relevant?
1999
1999
OBJECTIVE The aim of the study was to investigate the effects of the cytotoxic analog of luteinizing hormone-releasing hormone AN… (More)
Is this relevant?
1998
1998
To create cytotoxic hybrid analogs of somatostatin (SST), octapeptides RC-160 (D-Phe-Cys-Tyr-D-Trp- Lys-Val-Cys-Trp-NH2) and RC… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
1998
1998
Receptors for somatostatin (SST) that are found on prostate cancers might be used for targeting of chemotherapeutic agents. Thus… (More)
  • figure I
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Doxorubicin (DOX) and its daunosamine-modified derivative, 2-pyrrolino-DOX, which is 500-1000 times more active than DOX, were… (More)
Is this relevant?